Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis-Reference-Cited by-同舟云学术

Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis

Published:2020-08-10 Issue:9 Volume:23 Page:1233-1239
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int. J. Rheum. Dis.

Author:

Ma Jocelyn¹,Khalidi Nader²,Wierzbicki Ola²,Alqutami Abdallah³⁴,Ioannidis George²,Pagnoux Christian³^ORCID

Affiliation:

1. Toronto Western Hospital University of Toronto Toronto ON Canada

2. Division of Rheumatology St Joseph's Healthcare McMaster University Hamilton Canada

3. Vasculitis Clinic Mount Sinai Hospital University of Toronto Toronto ON Canada

4. Division of Rheumatology King Fahad Hospital Jeddah Saudi Arabia

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13914

Reference31 articles.

1. Clinical features of polymyalgia rheumatica and giant cell arteritis

2. Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes

3. Relapses in Patients With Giant Cell Arteritis

4. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis

5. Statin or Nonsteroidal Anti-Inflammatory Drug Use Is Associated With Lower Erythrocyte Sedimentation Rate in Patients With Giant Cell Arteritis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are the benefits and drawbacks of statins in carotid artery disease? A perspective review;Expert Review of Cardiovascular Therapy;2023-11-02

2. Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force;RMD Open;2023-06

3. Evaluation and quantification of compressor model predictive capabilities under modulation and extrapolation scenarios;International Journal of Refrigeration;2023-05

4. Épidémiologie et facteurs prédictifs de rechute de l’artérite à cellules géantes : revue systématique et méta-analyse;Revue du Rhumatisme;2023-05

5. Recent advances in the treatment of giant cell arteritis;Best Practice & Research Clinical Rheumatology;2023-03